Please login to the form below
ACT therapy
This page shows the latest ACT therapy news and features for those working in and with pharma, biotech and healthcare.
ACT immunotherapy cures terminal breast cancer patient
body - a “complete, durable regression” in the words of the scientists that developed the therapy. ... The ACT approach used by the researchers differs a little from chimeric antigen receptor T cell or CAR-T therapy, which have been approved for use
Latest news
-
Pipeline: Major depressive disorder therapeutics
ALKS 5461 is being developed as a once-daily therapy administered as a sublingual tablet. ... Brexpiprazole is a dopamine D2 partial agonist being developed as an oral adjunctive therapy.
-
Novartis to expand SMS for Life approach across Africa
In Tanzania, stock-outs of antimalarial treatment (Novartis' fixed-dose artemisinin-based combination therapy, or ACT, and quinine injectables) dropped from 79 per cent to less than 26 per cent in ... 2010 following the programme's debut, and the number
-
IQWiG knocks back Almirall's Eklira
No proof of an added benefit of aclidinium bromide compared with the appropriate comparator therapy (ACT) can be inferred from the data in the drug manufacturer's dossier,” it concluded.
-
Novartis compounds treat malaria in blood and liver
use. Moreover, there is a critical need for new malaria drugs in the face of emerging resistance even to the most effective artemisinin-based combination therapy (ACT) which was first encountered
-
Endo abuse-resistant pain drug rejected
The drug was granted a priority review last year. Under the programme, which is reserved for drugs that offer major advances in treatment or provide a treatment where no adequate therapy ... exists, the FDA aims to act on a new drug application (NDA)
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
The Holistic Approach to Market Access
These individuals are highly trained in therapy and product science and should have either a PhD in research or medical or a pharmacy background. ... Though the educational material must be unbiased toward a specific product, when well developed the
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- After the watershed: the dos and don’ts of digital KPIs in a post-pandemic world
- Imperial College London to lead major coronavirus home testing programme
- Regeneron says antibody for COVID-19 could be ready this year
- Moderna’s coronavirus vaccine hits first objectives
- UK’s new COVID-19 trial initiative fast-tracks BerGenBio’s bemcentinib
- Novartis to test canakinumab for COVID-19, as IL-6 trial disappoints
- AZ secures capacity for one billion coronavirus vaccine doses
- EMA starts review of MorphoSys’ tafasitamab for lymphoma
- Gilead, Galapagos dip on mixed ulcerative colitis data
- Roche makes protein degradation play with $135m Vividion deal
- Octapharma cleared to start phase 3 trial of Octagam in COVID-19
- UK government expands coronavirus testing criteria
No results were found
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
- Ben Speller shares his thoughts on the value of disease specific congresses...
- OPEN Health use PR to support clinical trial recruitment
- International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
- Covid-19: what could it mean for the diabetic population?
- Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...
Quick links
Infographics
